Panel discussion on novel therapies and targets for lymphoma
John Gribben et al.
The progress of CLL research: towards targeted therapy
BCR inhibitors improving CLL patient outcomes
Trials of BiTEs for the treatment of acute leukemias
iwNHL 2016 highlights: CAR T-cell therapy, DLBCL and new technologies